Author Topic: Words of caution about MS drug development  (Read 49 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 8124
  • MS diagnosed 1980
  • Location: Pacific Northwest
Words of caution about MS drug development
« on: January 13, 2018, 07:18:20 am »

This brief comment appears in Nature Reviews Neurology (January 12, 2018). The authors are well known in MS research. Timothy Coetzee is with the National MS Society in New York, and Alan M. Thompson is at the Faculty of Brain Sciences, University College London.  The title is "Unified understanding of MS course is required for drug development." The authors seem to be implying that  not enough is known yet about the MS disease course to justify the proliferation of MS drugs that we are currently seeing.

https://www.nature.com/articles/nrneurol.2017.184



MS Speaks--online for 12 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010.

 

Related Topics

  Subject / Started by Replies Last post
0 Replies
46 Views
Last post May 29, 2016, 04:39:51 pm
by agate
0 Replies
34 Views
Last post March 31, 2017, 04:18:03 pm
by agate
0 Replies
43 Views
Last post July 04, 2017, 03:58:12 pm
by agate
0 Replies
16 Views
Last post March 03, 2019, 09:18:48 pm
by agate
0 Replies
17 Views
Last post May 02, 2019, 07:28:24 pm
by agate